Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cor H J Lamers

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvantJohanna E A Portielje, Wim H J Kruit, Anke J M Eerenberg, et al.
Frontiers in Immunology|September 25, 2018
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOSPauline L de Goeje, Yarne Klaver, Margaretha E H Kaijen-Lambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumorsDiane A J van der Biessen, Herman Burger, Peter de Bruijn, et al.
Neuro-Oncology|May 18, 2012
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodiesAdriaan H C de Jongste, Marieke T de Graaf, Emanuela Martinuzzi, et al.
Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative StudiesErik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvantJohanna E A Portielje, Wim H J Kruit, Anke J M Eerenberg, et al.
Frontiers in Immunology|September 25, 2018
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOSPauline L de Goeje, Yarne Klaver, Margaretha E H Kaijen-Lambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumorsDiane A J van der Biessen, Herman Burger, Peter de Bruijn, et al.
Neuro-Oncology|May 18, 2012
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodiesAdriaan H C de Jongste, Marieke T de Graaf, Emanuela Martinuzzi, et al.
Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative StudiesErik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Pageof 3